18f faza pet imaging in tumor hypoxia a focus on high grade glioma

The presence of hypoxia is a typical feature of solid tumors and has been identified in many neoplasms, favouring the survival of malignant cells in a hostile environment and the expression of an aggressive phenotype. Malignant brain tumors have large proportions of hypoxic tissue, thus contributing to resistance to radiation and chemotherapy. Positron emission tomography (PET) is an attractive technique to gain a non-invasive assessment of tumor hypoxia within the whole tumor, with 18F-fluoromisonidazole (18F-FMISO) and 18F-flouroazomycin arabinoside (18F-FAZA) being the most promising radiotracers. In this short review, we aim to discuss the available clinical studies focused on the use of 18F-FAZA PET/computed tomography in patients affected by high-grade glioma

Clinical Indications of 11C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse

Several studies investigated the potential role of imaging modalities in prostate cancer patients in case of biochemical recurrence. However, the role of molecular imaging has not been well established yet. Considering the results of the literature and of our own experience, we tried to summarize the potential applications of 11C-choline PET/CT in prostate cancer patients in case of biochemical relapse for the detection of lymph node and distant recurrence

La culture de l’éducation de la petite enfance en Italie

Cet article retrace les étapes historiques qui ont jalonné la construction de la culture de la petite enfance, en Italie au cours des dernières décennies. Il présente les principaux éléments qui constituent cette culture aujourd’hui. Il met en évidence la contribution essentielle des institutions éducatives préscolaires à l’élaboration de cette culture qui s’est constituée, peu à peu, dans un enracinement profond dans les cultures locales des communes qui ont soutenu le développement de ces institutions et dans un lien étroit avec la recherche scientifique.This article retraces the milestones which have marked the development of an early childhood culture in Italy over the past decades. It presents the main elements that currently embody this culture. The article highlights the essential part played by pre-school educational institutions in creating this culture which gradually emerged by rooting itself deeply in the local culture of the towns which supported the development of these institutions and by forming a close partnership with scientific research.Este artículo presenta las etapas históricas que han marcado la construcción de una cultura de la pequeña infancia en Italia durante los últimos decenios. Expone los elementos principales que constituyen a día de hoy dicha cultura. Pone de manifiesto la contribución esencial de las instituciones educativas preescolares de cara a la elaboración de dicha cultura, que se ha ido constituyendo poco a poco, arraigándose profundamente en las culturas locales de los municipios que respaldaban el desarrollo de dichas instituciones y en estrecha colaboración con la investigación científica

Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance

Sézary syndrome (SS) is a rare and aggressive variant of Cutaneous T-Cell Lymphoma characterized by neoplastic distribution mainly involving blood, skin, and lymph-node. Although a role of the skin microenvironment in SS pathogenesis has long been hypothesized, its function in vivo is poorly characterized. To deepen this aspect, here we compared skin to blood-derived SS cells concurrently obtained from SS patients highlighting a greater proliferation-index and a PI3K/AKT/mTORC1 pathway activation level, particularly of mTOR protein, in skin-derived-SS cells. We proved that SDF-1 and CCL21 chemokines, both overexpressed in SS tissues, induce mTORC1 signaling activation, cell proliferation and Ki67 up-regulation in a SS-derived cell line and primary-SS cells. In a cohort of 43 SS cases, we observed recurrent copy number variations (CNV) of members belonging to this cascade, namely: loss of LKB1 (48%), PTEN (39%) and PDCD4 (35%) and gains of P70S6K (30%). These alterations represent druggable targets unraveling new therapeutic treatments as metformin here evaluated in vitro. Moreover, CNV of PTEN, PDCD4, and P70S6K, evaluated individually or in combination, are associated with reduced survival of SS patients. These data shed light on effects in vivo of skin-SS cells interaction underlying the prognostic and therapeutic relevance of mTORC1 pathway in SS

\u3csup\u3e68\u3c/sup\u3e Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis

Context: Gallium prostate-specific membrane antigen (PSMA) ligand Ga-HBED-CC-PSMA ( Ga-PSMA) is a promising radiotracer for positron emission tomography (PET)/computed tomography (CT) of prostate cancer. Objective: To conduct a meta-analysis to evaluate detection rate, diagnostic test accuracy, and adverse effects of Ga-PSMA PET/CT or PET/magnetic resonance imaging (MRI) for staging of prostate cancer and for restaging of rising prostate-specific antigen (PSA) after initial treatment. Evidence acquisition: Following the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) guidelines, our systematic review searched for articles in PubMed and EMBASE databases from 2012 to July 2016. The reference standard was pathology after biopsy or surgery. The analyses used a random effect model and a hierarchical summary receiver operating characteristic model. Evidence synthesis: Fifteen Ga-PSMA PET/CT studies with 1256 patients met the inclusion criteria. Seven studies of staging PET/CT or PET/MRI detected a regional site of cancer for 203 of 273 patients (74%). Nine studies of restaging PET/CT detected sites of recurrence in 799 of 983 patients (81%) with a 50% detection rate (74 of 147 patients) for restaging PSA of 0.2–0.49 ng/ml and a 53% detection rate (56 of 195 patients) for restaging PSA of 0.50–0.99 ng/ml. Staging Ga-PSMA PET/CT in the studies had higher detection rates of sites in the prostate bed than restaging Ga-PSMA PET/CT (mean 57% vs 14%, p = 0.031, t test). Both staging and restaging Ga-PSMA PET/CT found that a subgroup of the patients had metastatic sites in pelvic lymph nodes or distant organs. Eight studies of staging PET/CT undertook histologic correlations. We performed prostate-segment-based analysis specifically regarding the primary cancer lesion for four of these studies, and patient-based analysis specifically regarding pelvic lymph node metastases for four other studies. The pooled sensitivities for staging in the two groups of studies were 70% and 61%, and the pooled specificities were 84% and 97%. None of the studies reported complications from the PET/CT imaging. Conclusions: Ga-PSMA PET/CT has clinical relevance to detect sites of recurrence for patients with PSA recurrence after radical prostatectomy (RP) with PSA levels less than 1.0 ng/ml. Patient summary: Choline positron emission tomography (PET)/computed tomography (CT) can detect sites of recurrent prostate cancer in an earlier phase of prostate-specific antigen (PSA) recurrence than bone scans and CT scans, but choline PET/CT is rarely positive for patients with restaging PSA levels under 1 ng/ml. A new radiotracer called Ga-PSMA for PET/CT was able to detect sites of recurring cancer in up to 50% of patients who had an early rise in PSA exceeding 0.5 ng/ml after initial radical prostatectomy. The published studies did not report adverse effects of Ga-PSMA PET/CT imaging. The rate of detection of sites in the prostate bed was significantly higher for staging than for restaging positron emission tomography (PET) using a Ga-labeled prostate-specific membrane (PSMA) antigen ligand. Overall, the detection rate did not differ significantly between staging and restaging. The detection rate for restaging Ga-PSMA PET/computed tomography (CT) was 50% for restaging prostate-specific antigen (PSA) of 0.2–0.48 ng/ml, 53% for restaging PSA of 0.50–0.99 ng/ml, and higher for higher restaging PSA levels. Patient-based and lesion-based analysis of staging Ga-PSMA PET/CT had sensitivity of 61–70% and specificity of 84–97%. The studies did not report any adverse effects due to imaging. 68 68 68 68 68 68 68 68 68 68 68 68 68 6

Eliminating hepatitis C on the Balearic Islands, Spain: a protocol for an intervention study to test and link people who use drugs to treatment and care

Hepatology; Public health; VirologyHepatología; Salud pública; VirologíaHepatologia; Salut pública; VirologiaIntroduction The hepatitis C virus (HCV) is a highly infectious and deadly disease, affecting some 58 million people worldwide. Of the 1.13 million people living in the Balearic Islands, Spain, about 1350 individuals have untreated HCV. Of these, about 1120 (83%) are estimated to be people who use drugs (PWUD), who are one of the key at-risk groups for HCV infection globally. Carrying out micro-elimination approaches focused on this population is crucial to achieve the WHO goal of eliminating HCV by 2030. Thus, the primary objective of this study is to validate a model of care that simplifies the screening and linkage to HCV care pathways for PWUD on the Balearic Islands. Methods and analysis This intervention study will be implemented across 17 sites, in 4 different settings: addiction service centres (n=12), non-governmental organisation centres (n=3), a mobile methadone unit and a prison, with an estimated 3725 participants. Together with the healthcare staff at each centre, the intervention protocols will be adapted, focusing on four phases: recruitment and testing; linkage to care; treatment for those who test positive; and monitoring of sustained virological response 12 weeks after treatment and reinfection. The primary outcomes will be the number of tested and treated individuals and the secondary outcomes will include individuals lost at each step in the cascade of care. Descriptive analysis and multivariable logistic regression of the data will be undertaken. Ethics and dissemination The Hospital Clínic Barcelona, Spain, Ethics Committee approved this study on 18 February 2021 (HCB/2020/2018). Findings will be disseminated through peer-reviewed publications, conference presentations and social media. The results of this study could provide a model for targeting PWUD for HCV testing and treatment in the rest of Spain and in other settings, helping to achieve the WHO HCV elimination goal.This project is supported by Gilead Sciences, through the competitive research call HCV STAT

Fluorodeoxyglucose Uptake Measured by Positron Emission Tomography and Standardized Uptake Value Predicts Long-Term Survival of CT Screening Detected Lung Cancer in Heavy Smokers

n/

Lithium Borate Ionic Liquids as Single-Component Electrolytes for Batteries

Current electrolytes for lithium batteries are usually composed of at least two chemical compounds, an organic solvent such as a cyclic carbonate and a lithium salt such as LiPF6. Here, the concept of using a single-component electrolyte is demonstrated in lithium batteries based on new lithium borate ionic liquids at room temperature. The design concept of this class of lithium ionic liquids (LiILs) is based on an asymmetrically substituted central tetracoordinate boron atom with oligoethylene glycol groups, fluorinated electron-attracting groups, and one alkane group. The optimized borateLi+ LiILs show a high ionic conductivity value of >10−4 S cm−1 at 25 °C, high lithium transference numbers ( = 0.4 – 0.5) and electrochemical stability (>4 V). Some of the LiILs present high compatibility with lithium-metal electrodes showing stable polarization profiles in platting/stripping tests. The selected LiIL is investigated as single-component electrolytes in lithium-metal battery cells showing discharge capacity values in Li0/LiIL/lithium–iron phosphate and Li0/LiIL/lithium titanate cells of 124 and 75 mAh g−1, respectively, at a C-rate of 0.2 C and 65 °C with low-capacity loss.This work was funded and supported by a Grant for Basque Government through grant IT1309-19, and European Commission's funded Marie Skłodowska–Curie project POLYTE-EID (Project No. 765828) and Spanish MCIN/AEI/PID2020-119026GB-I00. G.G.-G. is grateful to “Secretaría de Educación, Ciencia, Tecnología e Innovación” from Ciudad de México for the postdoctoral fellowship through grant SECTEI/133/2019. G.G.-G. also thanks the PhD. IOSM for being the driving force and constant support

A novel model of care for simplified testing of HBV in African communities during the COVID-19 pandemic in Spain

Epidemiology; Health services; Viral hepatitisEpidemiologia; Serveis de salut; Hepatitis viralEpidemiología; Servicios de salud; Hepatitis viralChronic hepatitis B virus (HBV) infection is a major public health threat for migrant populations in Spain and efforts to scale up testing are needed to reach the WHO elimination targets. The Hepatitis B Virus Community Screening and Vaccination in Africans (HBV-COMSAVA) study aims to use point-of-care testing and simplified diagnostic tools to identify, link to care, or vaccinate African migrants in Barcelona during the COVID-19 pandemic. From 21/11/20 to 03/07/2021, 314 study participants were offered HBV screening in a community clinic. Rapid tests for HBsAg screening were used and blood samples were collected with plasma separation cards. Patients received results and were offered: linkage to specialist care; post-test counselling; or HBV vaccination in situ. Sociodemographic and clinical history were collected and descriptive statistics were utilized. 274 patients were included and 210 (76.6%) returned to receive results. The HBsAg prevalence was 9.9% and 33.2% of people had evidence of past resolved infection. Overall, 133 required vaccination, followed by post-test counselling (n = 114), and linkage to a specialist (n = 27). Despite the COVID-19 pandemic, by employing a community-based model of care utilizing novel simplified diagnostic tools, HBV-COMSAVA demonstrated that it was possible to diagnose, link to care, and vaccinate African migrants in community-based settings.This study was carried out by ISGlobal with competitive funding through the Gilead Sciences global HBV-CARE program (IN-ES-988–5799)